SomaLogic (SLGC) announced that Glass Lewis has recommended that SomaLogic stockholders vote for the pending merger with Standard BioTools (LAB) at the company’s special meeting of stockholders to be held on January 4. Together with the recommendation previously made by Institutional Shareholder Services, or ISS, on December 22 both of the independent proxy advisory firms have recommended that SomaLogic stockholders vote for the pending transaction.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SLGC:
- Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
- SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
- Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools
- SomaLogic corrects ‘Madryn Asset Management’s misleading disclosure’
- SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure